Retraction: MiR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells (PLoS ONE (2013) 8:6 (e64707) DOI: 10.1371/journal.pone.0064707);miR-23a Targets Interferon Regulatory Factor 1 and Modulates Cellular Proliferation and Paclitaxel-Induced Apoptosis in Gastric Adenocarcinoma Cells

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Liu, Xue ^a   Ru, Jing ^a   Zhang, Jian ^a   Zhu, Li hua ^a,b   Liu, Min ^a   Li, Xin ^a   Tang, Hua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HEBEI UNITED UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 1; MESSENGER RNA; MICRORNA; MICRORNA 23A; PACLITAXEL; UNCLASSIFIED DRUG; MIRN23 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; FLUORESCENCE ANALYSIS; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IRF1 GENE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; BIOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; NICK END LABELING; STOMACH TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; HUMANS; IN SITU NICK-END LABELING; INTERFERON REGULATORY FACTOR-1; MICRORNAS; PACLITAXEL; STOMACH NEOPLASMS;

EID: 84878827654     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0234093     Document Type: Erratum

References (48)

1. Abbasi SY, Taani HE, Saad A, Badheeb A, Addasi A, (2011) Advanced gastric cancer in jordan from 2004 to 2008: a study of epidemiology and outcomes. Gastrointest Cancer Res 4: 122-127.
2. Fock KM, Ang TL, (2010) Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol 25: 479-486.
3. Kim YH, Liang H, Liu X, Lee JS, Cho JY, et al. (2012) AMPKalpha modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. Cancer Res 72: 2512-2521.
4. Bornschein J, Rokkas T, Selgrad M, Malfertheiner P, (2011) Gastric cancer: clinical aspects, epidemiology and molecular background. Helicobacter 16Suppl 1: 45-52.
5. Mandong BM, Manasseh AN, Tanko MN, Echejoh GO, Madaki AJ, (2010) Epidemiology of gastric cancer in Jos University Teaching Hospital Jos a 20 year review of cases. Niger J Med 19: 451-454.
6. Shin A, Kim J, Park S, (2011) Gastric cancer epidemiology in Korea. J Gastric Cancer 11: 135-140.
7. Shridhar R, Dombi GW, Finkelstein SE, Meredith KL, Hoffe SE, (2011) Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: an analysis of the Surveillance, Epidemiology, and End Results database. Cancer 117: 3908-3916.
8. Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, et al. (2009) microRNA expression profile in undifferentiated gastric cancer. Int J Oncol 34: 537-542.
9. Li X, Zhang Y, Zhang H, Liu X, Gong T, et al. (2011) miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 9: 824-833.
10. Liu T, Tang H, Lang Y, Liu M, Li X, (2009) MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 273: 233-242.
11. Sun Q, Gu H, Zeng Y, Xia Y, Wang Y, et al. (2010) Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci 101: 2241-2247.
12. Zhu W, Shan X, Wang T, Shu Y, Liu P, (2010) miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer 127: 2520-2529.
13. Zhu W, Xu H, Zhu D, Zhi H, Wang T, et al. (2012) miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother Pharmacol 69: 723-731.
14. Zhu W, Zhu D, Lu S, Wang T, Wang J, et al. (2012) miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med Oncol 29: 384-391.
15. Nakajima A, Nishimura K, Nakaima Y, Oh T, Noguchi S, et al. (2009) Cell type-dependent proapoptotic role of Bcl2L12 revealed by a mutation concomitant with the disruption of the juxtaposed Irf3 gene. Proc Natl Acad Sci U S A 106: 12448-12452.
16. Cao M, Seike M, Soeno C, Mizutani H, Kitamura K, et al. (2012) MiR-23a regulates TGF-beta-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. Int J Oncol 41: 869-875.
17. Kong KY, Owens KS, Rogers JH, Mullenix J, Velu CS, et al. (2010) MIR-23A microRNA cluster inhibits B-cell development. Exp Hematol.38: 629-640e621.
18. Wang Z, Wei W, Sarkar FH, (2012) miR-23a, a critical regulator of "migR"ation and metastasis in colorectal cancer. Cancer Discov 2: 489-491.
19. Rathore MG, Saumet A, Rossi JF, de Bettignies C, Tempe D, et al. (2012) The NF-kappaB member p65 controls glutamine metabolism through miR-23a. Int J Biochem Cell Biol 44: 1448-1456.
20. Huang S, He X, Ding J, Liang L, Zhao Y, et al. (2008) Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer 123: 972-978.
21. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
22. Zhu LH, Liu T, Tang H, Tian RQ, Su C, et al. (2010) MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. FEBS J 277: 3726-3734.
23. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
24. Nozawa H, Oda E, Ueda S, Tamura G, Maesawa C, et al. (1998) Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer. Int J Cancer 77: 522-527.
25. Cavalli LR, Riggins RB, Wang A, Clarke R, Haddad BR, (2010) Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer. Breast Cancer Res Treat 121: 227-231.
26. Yamashita M, Toyota M, Suzuki H, Nojima M, Yamamoto E, et al. (2010) DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae. Cancer Sci 101: 1708-1716.
27. Dhayalan A, Kudithipudi S, Rathert P, Jeltsch A, (2011) Specificity analysis-based identification of new methylation targets of the SET7/9 protein lysine methyltransferase. Chem Biol 18: 111-120.
28. Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T, et al. (1997) Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 15: 1275-1281.
29. Hong S, Kim HY, Kim J, Ha HT, Kim YM, et al. (2013) Smad7 Protein Induces Interferon Regulatory Factor 1-dependent Transcriptional Activation of Caspase 8 to Restore Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis. J Biol Chem 288: 3560-3570.
30. Li P, Du Q, Cao Z, Guo Z, Evankovich J, et al. (2012) Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1). Cancer Lett 314: 213-222.
31. Muhie S, Hammamieh R, Cummings C, Yang D, Jett M (2012) Transcriptome characterization of immune suppression from battlefield-like stress. Genes Immun.
32. Stevens AM, Wang YF, Sieger KA, Lu HF, Yu-Lee LY, (1995) Biphasic transcriptional regulation of the interferon regulatory factor-1 gene by prolactin: involvement of gamma-interferon-activated sequence and Stat-related proteins. Mol Endocrinol 9: 513-525.
33. Lian J, Tian H, Liu L, Zhang XS, Li WQ, et al. (2010) Downregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1. Cell Death Dis 1: e94.
34. De Marchis ML, Ballarino M, Salvatori B, Puzzolo MC, Bozzoni I, et al. (2009) A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. Leukemia 23: 856-862.
35. Gao J, Senthil M, Ren B, Yan J, Xing Q, et al. (2010) IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells. Cell Death Differ 17: 699-709.
36. Ning Y, Riggins RB, Mulla JE, Chung H, Zwart A, et al. (2010) IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis. Mol Cancer Ther 9: 1274-1285.
37. Stang MT, Armstrong MJ, Watson GA, Sung KY, Liu Y, et al. (2007) Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells. Oncogene 26: 6420-6430.
38. Liu L, Qiu W, Wang H, Li Y, Zhou J, et al. (2012) Sublytic C5b-9 complexes induce apoptosis of glomerular mesangial cells in rats with Thy-1 nephritis through role of interferon regulatory factor-1-dependent caspase 8 activation. J Biol Chem 287: 16410-16423.
39. Lee SH, Kim JW, Lee HW, Cho YS, Oh SH, et al. (2003) Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression. Oncogene 22: 381-391.
40. Kikuchi S, (2002) Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer 5: 6-15.
41. Yamaoka Y, Kudo T, Lu H, Casola A, Brasier AR, et al. (2004) Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology 126: 1030-1043.
42. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485.
43. Schaefer BC, Paulson E, Strominger JL, Speck SH, (1997) Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Mol Cell Biol 17: 873-886.
44. Tang W, Morgan DR, Meyers MO, Dominguez RL, Martinez E, et al. (2012) Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile. Infect Agent Cancer 7: 21.
45. Lace MJ, Anson JR, Klingelhutz AJ, Harada H, Taniguchi T, et al. (2009) Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. Carcinogenesis 30: 1336-1344.
46. Alcantara FF, Tang H, McLachlan A, (2002) Functional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome. Nucleic Acids Res 30: 2068-2075.
47. Guidotti LG, Morris A, Mendez H, Koch R, Silverman RH, et al. (2002) Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J Virol 76: 2617-2621.
48. Su RC, Sivro A, Kimani J, Jaoko W, Plummer FA, et al. (2011) Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals. Blood 117: 2649-2657.